RSVpreF + qIRV

N/A

Report date: 2026/05/13 09:08:01

Base Information

Drug NameRSVpreF + qIRV

Drug Alias NamePF-07941314

ClassificationBiologics > Protein drugs > Recombinant proteinVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine > mRNA vaccineVaccines > Application > Prophylactic vaccine +[4]

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsRespiratory Syncytial Virus InfectionsInfluenza, Human

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited StatesSouth AfricaArgentina

CombinationsNo

Global Highest StatusPhase 3 Clinical

Highest Status in ChinaN/A

Originator CompaniesPfizer Inc

China Registration ClassN/A

Develop Information

Active CompaniesPfizer Inc

Inactive CompaniesN/A

Active IndicationsRespiratory Syncytial Virus InfectionsInfluenza, Human

Inactive IndicationsN/A

Other Information

ATC CodeN/A